• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAO-B PET 临床应用:使用 F-THK5351 检测神经退行性疾病。

Clinical application of MAO-B PET using F-THK5351 in neurological disorders.

机构信息

Diagnostic Neuroimaging Research, Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.

出版信息

Geriatr Gerontol Int. 2024 Mar;24 Suppl 1(Suppl 1):31-43. doi: 10.1111/ggi.14729. Epub 2023 Nov 16.

DOI:10.1111/ggi.14729
PMID:37973072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11503588/
Abstract

Monoamine oxidase B (MAO-B) is an enzyme localized to the outer mitochondrial membrane and highly concentrated in astrocytes. Temporal changes in regional MAO-B levels can be used as an index of astrocytic proliferation, known as activated astrocytes or astrogliosis. MAO-B is a marker to evaluate the degree of astrogliosis. Therefore, MAO-B positron emission tomography (PET) is a powerful imaging technique for visualizing and quantifying ongoing astrogliosis through the estimate of regional MAO-B levels. Each neurodegenerative disorder generally has a characteristic distribution pattern of astrogliosis secondary to neuronal loss and pathological protein aggregation. Therefore, by imaging astrogliosis, MAO-B PET can be used as a neurodegeneration marker for identifying degenerative lesions. Any inflammation in the brain usually accompanies astrogliosis starting from an acute phase to a chronic phase. Therefore, by imaging astrogliosis, MAO-B PET can be used as a neuroinflammation marker for identifying inflammatory lesions. MAO-B levels are high in gliomas originating from astrocytes but low in lymphoid tumors. Therefore, MAO-B PET can be used as a brain tumor marker for identifying astrocytic gliomas by imaging MAO-B levels and distinguishing between astrocytic and lymphoid tumors. This review summarizes the clinical application of MAO-B PET using F-THK5351 as markers for neurodegeneration, neuroinflammation, and brain tumors in neurological disorders. Because we assume that MAO-B PET is clinically applied to an individual patient, we focus on visual inspection of MAO-B images at the individual patient level. Geriatr Gerontol Int 2024; 24: 31-43.

摘要

单胺氧化酶 B(MAO-B)是一种定位于线粒体外膜的酶,高度集中在星形胶质细胞中。区域 MAO-B 水平的时间变化可作为星形胶质细胞增殖的指标,称为活化星形胶质细胞或星形胶质细胞增生。MAO-B 是评估星形胶质细胞增生程度的标志物。因此,MAO-B 正电子发射断层扫描(PET)是一种强大的成像技术,通过估计区域 MAO-B 水平来可视化和量化正在进行的星形胶质细胞增生。每种神经退行性疾病通常都有特征性的星形胶质细胞分布模式,继发于神经元丢失和病理性蛋白聚集。因此,通过成像星形胶质细胞,MAO-B PET 可用作识别退行性病变的神经退行性标志物。大脑中的任何炎症通常都伴有从急性期到慢性期的星形胶质细胞增生。因此,通过成像星形胶质细胞,MAO-B PET 可用作识别炎症病变的神经炎症标志物。源自星形胶质细胞的神经胶质瘤中 MAO-B 水平较高,而淋巴样肿瘤中 MAO-B 水平较低。因此,通过成像 MAO-B 水平,MAO-B PET 可用作脑肿瘤标志物,以识别星形胶质细胞瘤,并区分星形胶质细胞和淋巴样肿瘤。本综述总结了使用 F-THK5351 作为标志物的 MAO-B PET 在神经退行性疾病中的神经变性、神经炎症和脑肿瘤的临床应用。因为我们假设 MAO-B PET 应用于个体患者,所以我们专注于个体患者水平的 MAO-B 图像的视觉检查。老年医学与老年病学杂志 2024;24:31-43。

相似文献

1
Clinical application of MAO-B PET using F-THK5351 in neurological disorders.MAO-B PET 临床应用:使用 F-THK5351 检测神经退行性疾病。
Geriatr Gerontol Int. 2024 Mar;24 Suppl 1(Suppl 1):31-43. doi: 10.1111/ggi.14729. Epub 2023 Nov 16.
2
Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using F-THK5351 positron emission tomography.脑梗死患者星形胶质细胞增生的时间进程与症状改善的关系:使用 F-THK5351 正电子发射断层扫描监测的 1 例病例报告。
BMC Med Imaging. 2020 Jul 14;20(1):81. doi: 10.1186/s12880-020-00481-4.
3
First-in-Humans Evaluation of F-SMBT-1, a Novel F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis.首例人体 F-SMBT-1 评估:一种新型 F 标记单胺氧化酶-B PET 示踪剂,用于成像反应性星形胶质细胞增生。
J Nucl Med. 2022 Oct;63(10):1551-1559. doi: 10.2967/jnumed.121.263254. Epub 2022 Jan 27.
4
Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders.两种 MAO-B 放射性配体 18F-THK5351 和 11C-L-Deprenyl 的对头比较,以可视化神经障碍患者的星形胶质细胞增生。
Clin Nucl Med. 2021 Jan;46(1):e31-e33. doi: 10.1097/RLU.0000000000003197.
5
Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.健康大脑中单胺氧化酶 B 配体 18F-THK5351 的分布模式。
Clin Nucl Med. 2022 Jul 1;47(7):e489-e495. doi: 10.1097/RLU.0000000000004272. Epub 2022 May 12.
6
Monoamine oxidase B inhibitor, selegiline, reduces F-THK5351 uptake in the human brain.单胺氧化酶B抑制剂司来吉兰可降低人脑中F-THK5351的摄取。
Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y.
7
18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques.18F-THK5351 PET 可识别多发性硬化斑块中的星形胶质细胞增生。
Clin Nucl Med. 2020 Feb;45(2):e98-e100. doi: 10.1097/RLU.0000000000002751.
8
18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury.18F-THK5351 PET 可识别急性创伤性脑损伤的病灶。
Clin Nucl Med. 2020 Nov;45(11):e491-e492. doi: 10.1097/RLU.0000000000003165.
9
Neuroimaging-pathological correlations of [F]THK5351 PET in progressive supranuclear palsy.[F]THK5351 PET 神经影像学-病理学相关性在进行性核上性麻痹中的研究。
Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.
10
[F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.[F]F-DED PET 成像在神经退行性疾病中的反应性神经胶质增生:临床前概念验证和首例人体研究数据。
J Neuroinflammation. 2023 Mar 11;20(1):68. doi: 10.1186/s12974-023-02749-2.

本文引用的文献

1
Clinical Application of 18F-THK5351 PET to Identify Inflammatory Lesions Through Imaging Astrogliosis in a Case of Cytomegalovirus Ventriculoencephalitis.18F-THK5351 PET 在巨细胞病毒性脑室脑炎通过成像星形胶质细胞增生识别炎症病变中的临床应用。
Clin Nucl Med. 2023 Oct 1;48(10):e489-e490. doi: 10.1097/RLU.0000000000004809. Epub 2023 Aug 30.
2
Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome.中脑 18F-THK5351 分布模式的详细评估:与进行性核上性麻痹和皮质基底节综合征的比较。
Clin Nucl Med. 2023 Oct 1;48(10):841-846. doi: 10.1097/RLU.0000000000004815. Epub 2023 Sep 2.
3
High sensitivity of asymmetric F-THK5351 PET abnormality in patients with corticobasal syndrome.
不对称 F-THK5351 PET 异常在皮质基底节综合征患者中的高敏感性。
Sci Rep. 2023 Jul 27;13(1):12147. doi: 10.1038/s41598-023-39227-x.
4
Biomarker modeling of Alzheimer's disease using PET-based Braak staging.使用基于 PET 的 Braak 分期对阿尔茨海默病的生物标志物建模。
Nat Aging. 2022 Jun;2(6):526-535. doi: 10.1038/s43587-022-00204-0. Epub 2022 Apr 25.
5
18 F-THK5351 PET Can Evaluate Tumor Extension in Intravascular Large B-Cell Lymphoma : Comparison With 11C-Methionine PET and 18F-FDG PET.18F-THK5351 PET 可评估血管内大 B 细胞淋巴瘤的肿瘤侵犯程度:与 11C-蛋氨酸 PET 和 18F-FDG PET 的比较。
Clin Nucl Med. 2023 Apr 1;48(4):e204-e206. doi: 10.1097/RLU.0000000000004568. Epub 2023 Jan 20.
6
Brain PET Imaging of 11C-Methionine, 18F-FDG, and 18F-THK5351 in a Case of Lymphomatoid Granulomatosis.脑 PET 显像 11C-蛋氨酸、18F-FDG 和 18F-THK5351 在一例血管免疫母细胞性 T 细胞淋巴瘤中的应用。
Clin Nucl Med. 2022 Dec 1;47(12):e749-e751. doi: 10.1097/RLU.0000000000004388. Epub 2022 Sep 28.
7
Clinical Spectrum of Tauopathies.tau蛋白病的临床谱
Front Neurol. 2022 Jul 14;13:944806. doi: 10.3389/fneur.2022.944806. eCollection 2022.
8
Middle Cerebellar Peduncle in Early Stage of Multiple System Atrophy: A THK5351 PET Study.多系统萎缩早期的小脑中脚:一项THK5351正电子发射断层显像研究
Mov Disord. 2022 Sep;37(9):1957-1959. doi: 10.1002/mds.29143. Epub 2022 Jul 15.
9
Neuropathology and emerging biomarkers in corticobasal syndrome.皮质基底节综合征的神经病理学与新兴生物标志物
J Neurol Neurosurg Psychiatry. 2022 Jun 13;93(9):919-29. doi: 10.1136/jnnp-2021-328586.
10
Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.健康大脑中单胺氧化酶 B 配体 18F-THK5351 的分布模式。
Clin Nucl Med. 2022 Jul 1;47(7):e489-e495. doi: 10.1097/RLU.0000000000004272. Epub 2022 May 12.